WASHINGTON, Oct. 25 (UPI) -- A U.S. Food and Drug Administration official says the agency wants the government to approve restrictions on prescription painkillers such as Vicodin.
Dr. Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA, said by early December, the agency planned to submit a formal recommendation package to the U.S. Department of Health and Human Services to reclassify hydrocodone -- a opioid derived from codeine used orally as a painkiller and cough suppressant -- from Schedule III to Schedule II, which would impose new restrictions on how they are prescribed and used. For example, the new designation would limit the number of refills patients could receive before having a doctor write a new prescription.